1. Home
  2. HNNA vs VRCA Comparison

HNNA vs VRCA Comparison

Compare HNNA & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hennessy Advisors Inc.

HNNA

Hennessy Advisors Inc.

HOLD

Current Price

$10.10

Market Cap

78.0M

Sector

Finance

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$7.87

Market Cap

87.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNNA
VRCA
Founded
1989
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.0M
87.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
HNNA
VRCA
Price
$10.10
$7.87
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
3.8K
88.5K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
5.57%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$94.44
P/E Ratio
$8.77
N/A
Revenue Growth
N/A
370.22
52 Week Low
$8.90
$0.43
52 Week High
$13.19
$9.82

Technical Indicators

Market Signals
Indicator
HNNA
VRCA
Relative Strength Index (RSI) 59.30 64.91
Support Level $9.66 $7.24
Resistance Level $10.33 $8.24
Average True Range (ATR) 0.14 0.55
MACD 0.03 0.16
Stochastic Oscillator 90.08 70.64

Price Performance

Historical Comparison
HNNA
VRCA

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Share on Social Networks: